Problem

Malama Health addresses the fragmented, episodic care experienced by pregnant and postpartum women—especially Medicaid members and those with high-risk conditions. Its clearest use case is gestational diabetes: it affects roughly 8% of pregnancies, and unmanaged disease after delivery materially increases the risk of Type 2 diabetes. The problem extends beyond glucose control to missed follow-up, limited nutrition support, transportation and food insecurity, and disconnected clinical and community services. Medicaid is particularly important because it covers about four in ten U.S. births.

The economics are driven by preventable complications and downstream chronic disease. Malama cites evidence that 50% of women with gestational diabetes go on to develop Type 2 diabetes, a condition associated with roughly one in seven U.S. healthcare dollars. The company says its model is designed to improve outcomes and generate savings for payers, with an earlier Stanford description targeting a seven-to-one return on investment for health plans.

Product / Service

Malama is a doula-led maternal care provider combined with a technology and care-coordination platform. Patients receive a personalized care plan through the Malama app, use it to track glucose, blood pressure, weight, symptoms and other metrics between visits, and share data in real time with their care team. A HIPAA-compliant provider dashboard supports remote patient monitoring, risk escalation and reporting, with integrations including Epic. Community-based doulas and perinatal coaches are coordinated with nutritionists, lactation consultants, clinical teams and care managers.

The service is intended to replace purely episodic pregnancy care with continuous support from pregnancy through at least the first postpartum year. Doulas can provide home, virtual and birth support while care navigators connect families to benefits, food, transportation, childcare and other local resources. For Medicaid members, the wraparound service is offered at no cost to patients; Malama is reimbursed through health-plan arrangements, including per-member-per-month payments and quality incentives, while its remote-monitoring platform helps providers identify complications earlier, reduce administrative burden and avoid unnecessary visits.

Market

Malama competes in Medicaid-focused maternal health, digital health, remote patient monitoring and value-based doula care. Its model is differentiated by combining community-based doulas, clinical oversight, care navigation and monitoring infrastructure rather than offering only an app or a standalone doula network. The broader competitive set includes Wildflower Health, Maven Clinic and Mahmee, while adjacent maternal-care models include Oula Health, Pomelo Care and Nadia Care.

Malama is operating commercially rather than appearing pre-revenue: it reports being in-network with Medicaid plans in California, Texas and Colorado and being reimbursed through payer contracts. In March 2026 it announced a $9.2 million seed round led by Acumen America, supplemented by NIH and California funding, to expand into more Medicaid markets, grow its doula workforce and deepen health-system partnerships. Reported traction is significant but measured differently across sources: the company’s provider page lists more than 30,000 patients and 100-plus institutions, while March 2026 reporting says the app had been used by more than 45,000 women across all 50 states and had touched more than 600 clinics and hospitals; the same report cites patient-reported outcome improvements from more than 2,300 patients.